Beuschlein F - Search Results

1

Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial.

Baudin E, Goichot B, Berruti A, Hadoux J, Moalla S, Laboureau S, Nölting S, de la Fouchardière C, Kienitz T, Deutschbein T, Zovato S, Amar L, Haissaguerre M, Timmers H, Niccoli P, Faggiano A, Angokai M, Lamartina L, Luca F, Cosentini D, Hahner S, Beuschlein F, Attard M, Texier M, Fassnacht M; ENDOCAN-COMETE; ENSAT Networks. Baudin E, et al. Among authors: beuschlein f. Lancet. 2024 Mar 16;403(10431):1061-1070. doi: 10.1016/S0140-6736(23)02554-0. Epub 2024 Feb 22. Lancet. 2024. PMID: 38402886 Clinical Trial.

2

Steroidogenic acute regulatory protein mRNA expression in adrenal tumours.

Zenkert S, Schubert B, Fassnacht M, Beuschlein F, Allolio B, Reincke M. Zenkert S, et al. Among authors: beuschlein f. Eur J Endocrinol. 2000 Mar;142(3):294-9. doi: 10.1530/eje.0.1420294. Eur J Endocrinol. 2000. PMID: 10700725

3

Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma.

Beuschlein F, Strasburger CJ, Siegerstetter V, Moradpour D, Lichter P, Bidlingmaier M, Blum HE, Reincke M. Beuschlein F, et al. N Engl J Med. 2000 Jun 22;342(25):1871-6. doi: 10.1056/NEJM200006223422504. N Engl J Med. 2000. PMID: 10861322 Free article. No abstract available.

4

ACTH-receptor expression, regulation and role in adrenocortial tumor formation.

Beuschlein F, Fassnacht M, Klink A, Allolio B, Reincke M. Beuschlein F, et al. Eur J Endocrinol. 2001 Mar;144(3):199-206. doi: 10.1530/eje.0.1440199. Eur J Endocrinol. 2001. PMID: 11248736 Review.

5

Molecular adrenocortical tumourigenesis.

Reincke M, Beuschlein F, Slawik M, Borm K. Reincke M, et al. Among authors: beuschlein f. Eur J Clin Invest. 2000 Dec;30 Suppl 3:63-8. doi: 10.1046/j.1365-2362.2000.0300s3063.x. Eur J Clin Invest. 2000. PMID: 11281372 Review.

6

Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms.

Schubert B, Fassnacht M, Beuschlein F, Zenkert S, Allolio B, Reincke M. Schubert B, et al. Among authors: beuschlein f. Clin Endocrinol (Oxf). 2001 May;54(5):627-32. doi: 10.1046/j.1365-2265.2001.01253.x. Clin Endocrinol (Oxf). 2001. PMID: 11380493

7

Discerning malignancy in adrenocortical tumors: are molecular markers useful?

Wachenfeld C, Beuschlein F, Zwermann O, Mora P, Fassnacht M, Allolio B, Reincke M. Wachenfeld C, et al. Among authors: beuschlein f. Eur J Endocrinol. 2001 Sep;145(3):335-41. doi: 10.1530/eje.0.1450335. Eur J Endocrinol. 2001. PMID: 11517015

8

Role of the inhibin/activin system and luteinizing hormone in adrenocortical tumorigenesis.

Beuschlein F, Looyenga BD, Reincke M, Hammer GD. Beuschlein F, et al. Horm Metab Res. 2004 Jun;36(6):392-6. doi: 10.1055/s-2004-814584. Horm Metab Res. 2004. PMID: 15241730 Review.

9

Cytotoxic T-cell response against steroidogenic acute regulatory protein using DNA vaccination followed by vaccinia virus infection in a mouse adrenal carcinoma model.

Reincke M, Ortmann D, Hausmann J, Beuschlein F. Reincke M, et al. Among authors: beuschlein f. Horm Metab Res. 2004 Jun;36(6):411-4. doi: 10.1055/s-2004-814571. Horm Metab Res. 2004. PMID: 15241733

10

AKT is highly phosphorylated in pheochromocytomas but not in benign adrenocortical tumors.

Fassnacht M, Weismann D, Ebert S, Adam P, Zink M, Beuschlein F, Hahner S, Allolio B. Fassnacht M, et al. Among authors: beuschlein f. J Clin Endocrinol Metab. 2005 Jul;90(7):4366-70. doi: 10.1210/jc.2004-2198. Epub 2005 Apr 26. J Clin Endocrinol Metab. 2005. PMID: 15855265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters